SG11201909016TA - Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety - Google Patents

Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety

Info

Publication number
SG11201909016TA
SG11201909016TA SG11201909016TA SG11201909016TA SG 11201909016T A SG11201909016T A SG 11201909016TA SG 11201909016T A SG11201909016T A SG 11201909016TA SG 11201909016T A SG11201909016T A SG 11201909016TA
Authority
SG
Singapore
Prior art keywords
international
california
tiger
carlsbad
suite
Prior art date
Application number
Other languages
English (en)
Inventor
Michael P Bevilacqua
Daniel J Huang
Doug Looker
Original Assignee
Amicrobe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicrobe Inc filed Critical Amicrobe Inc
Publication of SG11201909016TA publication Critical patent/SG11201909016TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11201909016T 2017-04-06 2018-04-05 Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety SG11201909016TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762482630P 2017-04-06 2017-04-06
PCT/US2018/026322 WO2018187617A1 (fr) 2017-04-06 2018-04-05 Compositions et utilisations d'antimicrobiens appliqués localement présentant des performances et une sécurité améliorées

Publications (1)

Publication Number Publication Date
SG11201909016TA true SG11201909016TA (en) 2019-10-30

Family

ID=63712780

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909016T SG11201909016TA (en) 2017-04-06 2018-04-05 Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety

Country Status (12)

Country Link
US (2) US11285189B2 (fr)
EP (1) EP3606543A4 (fr)
JP (2) JP2020513016A (fr)
KR (1) KR20200018400A (fr)
CN (1) CN110740744A (fr)
AU (2) AU2018249552A1 (fr)
BR (1) BR112019020781A2 (fr)
CA (1) CA3058901A1 (fr)
MX (1) MX2022007904A (fr)
RU (1) RU2019133628A (fr)
SG (1) SG11201909016TA (fr)
WO (1) WO2018187617A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2680959C2 (ru) 2012-03-23 2019-03-01 Амикроб, Инк. Композиции и применение противомикробных материалов со свойствами биологической совместимости
KR20200018400A (ko) 2017-04-06 2020-02-19 아미크로베, 인코포레이티드. 개선된 성능 및 안전성을 가진 국소적으로 적용된 항균제의 조성물 및 용도
CA3159941A1 (fr) 2019-11-08 2021-05-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions comprenant des peptides antimicrobiens
AU2021246472B2 (en) * 2020-03-31 2023-10-26 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
EP4132468A4 (fr) * 2020-04-08 2024-04-17 Amicrobe, Inc. Compositions et utilisations de polymères d'acides aminés synthétiques appliqués localement pour la prévention et le traitement d'infections virales

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CA2689696C (fr) 1999-02-26 2013-08-06 Novartis Vaccines And Diagnostics, Inc. Microemulsions a macromolecules et microparticules adsorbees
SG137691A1 (en) 2000-09-28 2007-12-28 Chiron Corp Microparticles for delivery of the heterologous nucleic acids
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US6818732B2 (en) 2001-08-30 2004-11-16 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (ja) * 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造法
CA2443472A1 (fr) 2002-02-07 2003-08-14 Ophtecs Corporation Preparation liquide pour lentilles de contact
AU2003299590B8 (en) 2002-12-09 2010-04-08 Abraxis Bioscience, Llc Compositions and methods of delivery of pharmacological agents
ES2302034T3 (es) 2003-07-11 2008-07-01 Theravance, Inc. Antibioticos de cefalosporina-glicopeptido reticulados.
WO2005018701A1 (fr) 2003-08-25 2005-03-03 Kane Biotech Inc. Compositions antimicrobiennes synergiques et procedes d'inhibition de la formation de biofilms
DE602004012894T2 (de) 2003-12-30 2009-05-14 Bioactive Polymers Ab Oberflächenschutz von frei liegenden biologischen geweben
ES2297688T3 (es) * 2004-03-12 2008-05-01 Intercell Ag Procedimiento para solubizar mezclas de peptidos.
EP3141559A1 (fr) 2004-08-18 2017-03-15 Novabiotics Limited Peptides antimicrobiens
JP5118023B2 (ja) 2005-06-06 2013-01-16 ノボザイムス アデニウム バイオテック アクティーゼルスカブ 抗菌作用を有するポリペプチド、およびそのポリペプチドをコードするポリヌクレオチド
US20080139450A1 (en) 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
WO2007095005A1 (fr) 2006-02-10 2007-08-23 Z-Medica Corporation Agents et dispositifs pour conferer aux plaies des fonctions de coagulation sanguine
WO2008070571A2 (fr) 2006-12-01 2008-06-12 The Regents Of The University Of California Vésicules de copolymères séquencés à auto-assemblage, et procédés de fabrication et d'utilisation de ceux-ci
US9034815B2 (en) 2007-01-10 2015-05-19 Moerae Matrix, Inc Polypeptide for treating or preventing adhesions
EP2173389A2 (fr) 2007-06-25 2010-04-14 Lipopeptide AB Nouveaux produits médicaux
WO2009032605A2 (fr) 2007-08-27 2009-03-12 Massachusetts Institute Of Technology Inhibiteurs du virus de la grippe couplés à un polymère bifonctionnel
CN102065901B (zh) 2008-06-19 2013-03-06 日本新药株式会社 药物载体
CA2750340C (fr) 2009-01-23 2017-09-19 Kane Biotech Inc. Compositions antimicrobiennes eliminant les biopellicules et leurs applications
GB0905451D0 (en) 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
AU2011247584B2 (en) 2010-04-27 2016-01-14 Lysando Ag Method of reducing biofilms
MX342039B (es) 2010-08-23 2016-09-09 The Regents Of The Univ Of California * Composiciones y usos de materiales con actividad antimicrobiana elevada y toxicidad baja referencia cruzada a solicitudes previas.
CN103370087A (zh) * 2011-01-19 2013-10-23 目立康株式会社 隐形眼镜用液体制剂
US9781949B2 (en) 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
RU2680959C2 (ru) * 2012-03-23 2019-03-01 Амикроб, Инк. Композиции и применение противомикробных материалов со свойствами биологической совместимости
DE102014101663A1 (de) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
US10351599B2 (en) 2014-09-19 2019-07-16 Tensive Controls, Inc. Anti-microbial peptides
US20160120936A1 (en) * 2014-10-30 2016-05-05 Karen Troxel Methods of preventing surgical site infections
JP2016113373A (ja) * 2014-12-11 2016-06-23 エスポ化学株式会社 抗菌性、抗ウイルス性を有する水溶性組成物
KR20200018400A (ko) 2017-04-06 2020-02-19 아미크로베, 인코포레이티드. 개선된 성능 및 안전성을 가진 국소적으로 적용된 항균제의 조성물 및 용도
US20210007999A1 (en) 2018-03-02 2021-01-14 January Therapeutics, Inc. Nanoparticle compositions

Also Published As

Publication number Publication date
BR112019020781A2 (pt) 2020-04-28
RU2019133628A3 (fr) 2021-07-14
AU2023202283A1 (en) 2023-05-11
EP3606543A1 (fr) 2020-02-12
WO2018187617A1 (fr) 2018-10-11
WO2018187617A8 (fr) 2019-10-17
CN110740744A (zh) 2020-01-31
CA3058901A1 (fr) 2018-10-11
JP2020513016A (ja) 2020-04-30
AU2018249552A1 (en) 2019-10-31
US20210100867A1 (en) 2021-04-08
MX2022007904A (es) 2022-07-21
EP3606543A4 (fr) 2020-12-16
US11285189B2 (en) 2022-03-29
KR20200018400A (ko) 2020-02-19
US20230017994A1 (en) 2023-01-19
JP2023054375A (ja) 2023-04-13
RU2019133628A (ru) 2021-05-06

Similar Documents

Publication Publication Date Title
SG11201909016TA (en) Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
SG11201908420WA (en) Compositions of plinabulin and use thereof
SG11201908560SA (en) Heterocyclic compounds useful as dual atx/ca inhibitors
SG11201900596XA (en) Cannabis composition
SG11201908330PA (en) Farnesoid x receptor agonists and uses thereof
SG11201809751XA (en) Egfr inhibitor compounds
SG11201908547VA (en) Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
SG11201809082WA (en) Nlrp3 modulators
SG11201907742YA (en) Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof
SG11201811490XA (en) Cd3 binding antibodies
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201906885TA (en) Methods for the administration of certain vmat2 inhibitors
SG11201907544VA (en) Jak inhibitors containing a 4-membered heterocyclic amide
SG11201900501RA (en) Cannabis composition
SG11201907023UA (en) Method of reducing neutropenia
SG11201908179UA (en) Aryl cyclopropyl-amino-isoquinolinyl amide compounds
SG11201811230RA (en) Compositions and methods for reducing ocular neovascularization
SG11201408173WA (en) Pyrimidinyl tyrosine kinase inhibitors
CA3025288C (fr) Compositions alcalines et neutres de nettoyage, d'aseptisation et de desinfection a faible embuage par l'utilisation de polymeres en emulsion d'eau dans l'huile a masse moleculaire elevee
SG11201806583XA (en) Compositions containing tucaresol or its analogs
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof